Table 2 Subgroup analysis of the pooled HRs of overall survival with over-expressed NEAT1 in patients with cancer.
From: The Value of lncRNA NEAT1 as a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis
Subgroup analysis | No. of studies | No.of patients | Pooled HR (95% CI) | Heterogeneity | ||
|---|---|---|---|---|---|---|
Fix/Random | p Value | I2(%) | p Value | |||
Sample size | ||||||
≥100 | 5 | 2659 | 1.61 (1.24, 2.08) | <0.001 | 59.7 | 0.030 |
<100 | 4 | 343 | 2.15 (1.45, 3.19) | <0.001 | 0.0 | 0.943 |
Type of methods | ||||||
qRT-PCR | 8 | 1002 | 1.85 (1.54, 2.24) | <0.001 | 0.0 | 0.661 |
Other methods | 1 | 2000 | 1.22 (1.06, 1.41) | 0.006 | — | — |
